HUBUNGAN USIA, LAMA PEMAKAIAN SUNTIK PROGESTIN DENGAN KEJADIAN HIPERTENSI PADA AKSEPTOR KB SUNTIK PROGESTIN DI TEMPAT PRAKTEK MANDIRI BIDAN A DESA DAWUAN KECAMATAN CIKAMPEK KABUPATEN KARAWANG PROVINSI JAWA BARAT 2024
Keywords:
Age, Duration of use, Hypertension, Family Planning AcceptorsAbstract
Family planning is an effort to regulate the birth of children, the distance and ideal age of childbirth, regulate pregnancy through promotion, protection, and assistance in accordance with reproductive rights to create a quality family. The majority of family planning users are new family planning users who use non-permanent contraceptive methods (Non MKJP), which is 79.81% of all new family planning participants, although new family planning participants who use long-term contraceptive methods (MKJP) almost reached the target of 20.50% with an achievement of 20.19% in 2015 (BKKBN, 2015). However, the recommended contraceptive for the KKBPK (Population, Family Planning and Family Development) programme is MKJP (BPS, 2018). Hormonal contraception is often associated with the risk of cardiovascular disease. Some diseases include hypertension, cerebrovasculare diseases, deep vein thrombosis, venous thromboembolism (Susanti and Satriyanto, 2018).This research design uses quantitative research methods with a crossectional approach using secondary data taken from the KB register book with a population of 131 progestin injectable contraceptive acceptors at TPMB Midwife A Kab Karawang 2024. Data analysis was done univariately and bivariate with chi square test. The results of the study found that there was a relationship between age, duration of progestin injection use with the incidence of hypertension where the P value was 0.000 with OR Age (53.545) meaning that old age (≥ 40 years) was 53.5 times more at risk of developing hypertension, compared to young age (18-39 years). And OR Length of use of progestin injections (22.727) which means the use of progestin injections (≥ 2 years) is 22.7 times more at risk of developing hypertension, compared to the use of progestin injections (< 2 years) who experience hypertension. To every health worker, especially midwives, can develop counselling methods for high-risk progestin injecting acceptors (> 40 years old) to be more selective in choosing contraceptives used and it is better to use non-hormonal contraceptives. Then to low-risk progestin injecting acceptors (18 - 40 years old) provide further education about setting the right distance of contraception use, because if it is too long it can cause hypertension.